Across TCGA pan-cancer cohorts, DUSP29 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of DUSP29’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where DUSP29 RNA is repressed in tumor relative to normal tissue. In most cancer types DUSP29 is over-expressed in tumor, although a few such as HNSC and PAAD show the opposite, repressed pattern.

HNSC, KIRC, and PAAD are the cancer types where DUSP29 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DUSP29 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	−1.223	.002	8	view →
KIRC	All	All	+0.022	.004	6	view →
PAAD	Male	All	−0.145	.010	4	view →
STAD	All	IV	−0.236	.036	1	view →
COAD	All	II,III,IV	−0.030	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: DUSP29 RNA expression & survival · all DUSP29 data types